{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:10:03Z","timestamp":1773288603860,"version":"3.50.1"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tunisian Ministry of Public Health, the Ministry of Higher Education and Scientific Research","award":["(LR11IPT05), Institut Pasteur in Tunis"],"award-info":[{"award-number":["(LR11IPT05), Institut Pasteur in Tunis"]}]},{"name":"European Commission E.C.","award":["Grant agreement no. 279171-1 for FP7 project MEDIGENE, Institut Pasteur in Tunis"],"award-info":[{"award-number":["Grant agreement no. 279171-1 for FP7 project MEDIGENE, Institut Pasteur in Tunis"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194842","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T19:08:19Z","timestamp":1523646499000},"page":"e0194842","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations"],"prefix":"10.1371","volume":"13","author":[{"given":"Haifa","family":"Jmel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Romdhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Ben Halima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Hechmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chokri","family":"Naouali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Dallali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosr","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelmajid","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henda","family":"Jamoussi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotfi","family":"Chouchane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donata","family":"Luiselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Abdelhak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8801-5781","authenticated-orcid":true,"given":"Rym","family":"Kefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12863-015-0232-x","article-title":"Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China","volume":"16","author":"L Wang","year":"2015","journal-title":"BMC genetics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-genom-090413-025419","article-title":"Personalized pharmacogenomics: predicting efficacy and adverse drug reactions","volume":"15","author":"M Pirmohamed","year":"2014","journal-title":"Annual review of genomics and human genetics"},{"issue":"10","key":"ref3","first-page":"13293","article-title":"Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China","volume":"8","author":"Y He","year":"2015","journal-title":"International journal of clinical and experimental pathology"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra020021","article-title":"Inheritance and drug response","volume":"348","author":"R Weinshilboum","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tig.2003.09.008","article-title":"Pharmacogenetics: potential for individualized drug therapy through genetics","volume":"19","author":"JA Johnson","year":"2003","journal-title":"Trends in genetics: TIG"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1146\/annurev.genom.2.1.9","article-title":"Pharmacogenomics: the inherited basis for interindividual differences in drug response","volume":"2","author":"WE Evans","year":"2001","journal-title":"Annual review of genomics and human genetics"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomics\u2014drug disposition, drug targets, and side effects","volume":"348","author":"WE Evans","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/clpt.2008.141","article-title":"The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies","volume":"84","author":"SU Yasuda","year":"2008","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00003088-198207050-00001","article-title":"Ethnic differences in drug metabolism","volume":"7","author":"W Kalow","year":"1982","journal-title":"Clinical pharmacokinetics"},{"issue":"19\u201320","key":"ref10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.drudis.2011.08.008","article-title":"Pharmacogenetics: practices and opportunities for study design and data analysis","volume":"16","author":"AA Flynn","year":"2011","journal-title":"Drug discovery today"},{"issue":"5\u20136","key":"ref11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5489\/cuaj.1884","article-title":"Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours","volume":"8","author":"AL Millman","year":"2014","journal-title":"Canadian Urological Association journal = Journal de l\u2019Association des urologues du Canada"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/pgs.14.102","article-title":"Personalized pharmacogenomics profiling using whole-genome sequencing","volume":"15","author":"C Mizzi","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"6934","key":"ref13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature01626","article-title":"A vision for the future of genomics research","volume":"422","author":"FS Collins","year":"2003","journal-title":"Nature"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1017\/S1368980012003291","article-title":"Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project","volume":"16","author":"H Belfki","year":"2013","journal-title":"Public health nutrition"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.pap.0000249936.05650.0c","article-title":"Metabolic syndrome: treatment of hypertensive patients","volume":"14","author":"ZH Israili","year":"2007","journal-title":"American journal of therapeutics"},{"issue":"44","key":"ref16","doi-asserted-by":"crossref","first-page":"17758","DOI":"10.1073\/pnas.1212380109","article-title":"The great human expansion","volume":"109","author":"BM Henn","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00228-014-1641-x","article-title":"CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients","volume":"70","author":"J Klen","year":"2014","journal-title":"European journal of clinical pharmacology"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/dc15-2464","article-title":"CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes","volume":"39","author":"AY Dawed","year":"2016","journal-title":"Diabetes care"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/0091270009355161","article-title":"Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans","volume":"50","author":"M Man","year":"2010","journal-title":"Journal of clinical pharmacology"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00228-009-0768-7","article-title":"Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements","volume":"66","author":"J Cadamuro","year":"2010","journal-title":"European journal of clinical pharmacology"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1111\/j.1582-4934.2012.01606.x","article-title":"Analysis of CYP2C9*2, CYP2C9*3 and VKORC1\u20131639 G>A polymorphisms in a population from South-Eastern Europe","volume":"16","author":"AD Buzoianu","year":"2012","journal-title":"Journal of cellular and molecular medicine"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/blood-2005-01-0341","article-title":"Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity","volume":"106","author":"L Bodin","year":"2005","journal-title":"Blood"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bcp.12980","article-title":"Peripheral vasoconstriction induced by beta-adrenoceptor blockers: a systematic review and a network meta-analysis","volume":"82","author":"C Khouri","year":"2016","journal-title":"British journal of clinical pharmacology"},{"issue":"13","key":"ref24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-Drug Therapy for Hypertension in Men\u2014A Comparison of Six Antihypertensive Agents with Placebo","volume":"328","author":"BJ Materson","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"JL Mega","year":"2010","journal-title":"Jama"},{"key":"ref26","article-title":"Landscape of warfarin and clopidogrel pharmacogenetic variants in Qatari population from whole exome datasets","author":"A Sivadas","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12041-015-0581-2","article-title":"Characterization of drug-metabolizing enzymes CYP2C9, CYP2C19 polymorphisms in Tunisian, Kuwaiti and Bahraini populations","volume":"94","author":"R Abdelhedi","year":"2015","journal-title":"Journal of genetics"},{"issue":"17","key":"ref28","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2217\/pgs-2016-0130","article-title":"Landscape of warfarin and clopidogrel pharmacogenetic variants in Qatari population from whole exome datasets","volume":"17","author":"A Sivadas","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"22","key":"ref29","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1161\/CIRCULATIONAHA.107.183679","article-title":"Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group","volume":"115","author":"DK Arnett","year":"2007","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1479-5876-11-121","article-title":"Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians","volume":"11","author":"J Shan","year":"2013","journal-title":"Journal of translational medicine"},{"key":"ref31","unstructured":"Carvalho B. Genotyping with the crlmm Package. 2009."},{"key":"ref32"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"The American Journal of Human Genetics"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"e1002397","DOI":"10.1371\/journal.pgen.1002397","article-title":"Genomic ancestry of North Africans supports back-to-Africa migrations","volume":"8","author":"BM Henn","year":"2012","journal-title":"PLoS genetics"},{"issue":"5866","key":"ref35","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.1153717","article-title":"Worldwide human relationships inferred from genome-wide patterns of variation","volume":"319","author":"JZ Li","year":"2008","journal-title":"Science (New York, NY)"},{"issue":"24","key":"ref36","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","article-title":"A high-performance computing toolset for relatedness and principal component analysis of SNP data","volume":"28","author":"X Zheng","year":"2012","journal-title":"Bioinformatics"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/genetics\/164.4.1567","article-title":"Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies","volume":"164","author":"D Falush","year":"2003","journal-title":"Genetics"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/genetics\/155.2.945","article-title":"Inference of population structure using multilocus genotype data","volume":"155","author":"JK Pritchard","year":"2000","journal-title":"Genetics"},{"key":"ref39","article-title":"rgl: 3D visualization device system (OpenGL)","volume":"798","author":"D Adler","year":"2012","journal-title":"R package version 092"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"JR Gonz\u00e1lez","year":"2007","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"1","key":"ref41","first-page":"184","article-title":"Hierfstat, a package for R to compute and test hierarchical F\u2010statistics","volume":"5","author":"J Goudet","year":"2005","journal-title":"Molecular Ecology Resources"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1471-8286.2007.01758.x","article-title":"Inference of population structure using multilocus genotype data: dominant markers and null alleles","volume":"7","author":"D Falush","year":"2007","journal-title":"Molecular ecology notes"},{"issue":"8","key":"ref43","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1365-294X.2005.02553.x","article-title":"Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study","volume":"14","author":"G Evanno","year":"2005","journal-title":"Molecular ecology"},{"issue":"14","key":"ref44","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/bioinformatics\/btm233","article-title":"CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure","volume":"23","author":"M Jakobsson","year":"2007","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1471-8286.2003.00566.x","article-title":"DISTRUCT: a program for the graphical display of population structure","volume":"4","author":"NA Rosenberg","year":"2004","journal-title":"Molecular Ecology Notes"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"e0162866","DOI":"10.1371\/journal.pone.0162866","article-title":"A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics","volume":"11","author":"C Mizzi","year":"2016","journal-title":"PloS one"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"e112640","DOI":"10.1371\/journal.pone.0112640","article-title":"Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations","volume":"9","author":"V Bonifaz-Pena","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajpa.21581","article-title":"Genetic structure of Tunisian ethnic groups revealed by paternal lineages","volume":"146","author":"K Fadhlaoui-Zid","year":"2011","journal-title":"American journal of physical anthropology"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/19401736.2013.879649","article-title":"Phylogeny and genetic structure of Tunisians and their position within Mediterranean populations","volume":"26","author":"R Kefi","year":"2015","journal-title":"Mitochondrial DNA"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ajpa.23008","article-title":"Genetic variation in Tunisia in the context of human diversity worldwide","volume":"161","author":"L Cherni","year":"2016","journal-title":"American journal of physical anthropology"},{"issue":"18","key":"ref51","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2009-12-255992","article-title":"Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups","volume":"115","author":"NA Limdi","year":"2010","journal-title":"Blood"},{"issue":"24","key":"ref52","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa1311388","article-title":"A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon","volume":"369","author":"TI Verhoef","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"e0116463","DOI":"10.1371\/journal.pone.0116463","article-title":"Warfarin dosage response related pharmacogenetics in Chinese population","volume":"10","author":"S Li","year":"2015","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.biochem.71.102301.093055","article-title":"Mammalian ABC transporters in health and disease","volume":"71","author":"P Borst","year":"2002","journal-title":"Annual review of biochemistry"},{"issue":"1\u20133","key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00744656","article-title":"P-glycoprotein structure and evolutionary homologies","volume":"12","author":"JM Croop","year":"1993","journal-title":"Cytotechnology"},{"issue":"10","key":"ref56","doi-asserted-by":"crossref","first-page":"e46366","DOI":"10.1371\/journal.pone.0046366","article-title":"ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysis","volume":"7","author":"J Su","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/CIRCULATIONAHA.108.773267","article-title":"Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin","volume":"118","author":"MW Medina","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"P Kuehl","year":"2001","journal-title":"Nature genetics"},{"issue":"1\u20132","key":"ref59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2008.07.032","article-title":"CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia","volume":"398","author":"MA Willrich","year":"2008","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01213011-200506000-00007","article-title":"Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage","volume":"15","author":"RA Wilke","year":"2005","journal-title":"Pharmacogenetics and genomics"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00008571-200308000-00004","article-title":"Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups","volume":"13","author":"SJ Lee","year":"2003","journal-title":"Pharmacogenetics"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2133\/dmpk.DMPK-11-RV-111","article-title":"Population differences in major functional polymorphisms of pharmacokinetics\/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development","volume":"27","author":"K Kurose","year":"2012","journal-title":"Drug metabolism and pharmacokinetics"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2156-14-34","article-title":"Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa","volume":"14","author":"RK Bains","year":"2013","journal-title":"BMC genetics"},{"issue":"12","key":"ref64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00109-006-0108-7","article-title":"Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women","volume":"84","author":"SE Humphries","year":"2006","journal-title":"Journal of molecular medicine (Berlin, Germany)"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/db07-0440","article-title":"Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study","volume":"56","author":"ER Pearson","year":"2007","journal-title":"Diabetes"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"415149","DOI":"10.1155\/2015\/415149","article-title":"Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?","volume":"2015","author":"C Pollastro","year":"2015","journal-title":"PPAR research"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.17305\/bjbms.2010.2662","article-title":"Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus","volume":"10","author":"S Semiz","year":"2010","journal-title":"Bosnian journal of basic medical sciences"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2105-13-258","article-title":"DMET-analyzer: automatic analysis of Affymetrix DMET data","volume":"13","author":"PH Guzzi","year":"2012","journal-title":"BMC bioinformatics"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-60761-663-4_7","article-title":"DMET microarray technology for pharmacogenomics-based personalized medicine","volume":"632","author":"JK Burmester","year":"2010","journal-title":"Methods in molecular biology (Clifton, NJ)"},{"issue":"33","key":"ref70","doi-asserted-by":"crossref","first-page":"54028","DOI":"10.18632\/oncotarget.9927","article-title":"DMET (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine","volume":"7","author":"M Arbitrio","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dmpk.2015.11.007","article-title":"The population genetics of pharmacogenomics VIP variants in the Sherpa population","volume":"31","author":"L Wang","year":"2016","journal-title":"Drug metabolism and pharmacokinetics"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/321272","article-title":"Are rare variants responsible for susceptibility to complex diseases?","volume":"69","author":"JK Pritchard","year":"2001","journal-title":"American journal of human genetics"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/FTD.0b013e3181fcf94d","article-title":"Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine","volume":"33","author":"DE McAlpine","year":"2011","journal-title":"Therapeutic drug monitoring"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T15:31:45Z","timestamp":1660923105000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194842"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Novelli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194842","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]}}}